Pinned Tweet
Our latest study in @nature reveals how #TGFβ drives Epstein-Barr Virus (#EBV) reactivation in multisystem inflammatory syndrome in #children (#MISC, #PIMS) following #COVID19. @DRFZ_Berlin @Mashreghi_Lab #SARSCoV2 @ChariteBerlin
🔗 Read here: nature.com/articles/s41586-0…
Mashreghi_Lab retweeted
The Immune Alliance Meeting is in full swing in Bayreuth, with a spectacular speaker line-up and exciting new findings that may well challenge some textbook knowledge. An inspiring meeting full of cutting-edge immunology and lively scientific exchange! #immunology
Mashreghi_Lab retweeted
A great opening of our Immune Alliance Meeting 2026 in Bayreuth with Nobel Laureate Shimon Sakaguchi presenting his latest work on the role of Treg cells in cancer immunity. #immunology
Mashreghi_Lab retweeted
0/ Out in Science Translational Medicine
science.org/doi/10.1126/scit…
Nice to see our @Nature paper (rdcu.be/e4o4z) validated again, even without a citation. Prolonged TGF-β locks NK cells in dysfunction. biorxiv.org/content/10.64898…
113
Confirmation is welcome: TGF-β–driven pathology in severe COVID-19 and post/longCOVID;rdcu.be/e2vBi; rdcu.be/e2vFn; were described by us in 2021 rdcu.be/e2vHo and in a defining post-COVID disease rdcu.be/e2vIL, (2025). Regrettably, uncited
New paper out in Nature Communications
Huge congrats to Lennard Ostendorf and Tobias Alexander on a really impressive phase 2 trial in SLE. Very happy to have contributed to this work. nature.com/articles/s41467-0…
1
1
112
This work strongly supports ASCs as central drivers of disease activity in SLE, and CD38 as a clinically actionable target—opening the door for smarter combination or sequential therapies.
Big kudos to the whole team for pulling together clinical trial execution, single-cell biology, and translational immunology so elegantly.
Honored to have been part of this effort. @Mashreghi_Lab @ChariteBerlin German_Rheumatology Research Center; DRFZ @LeibnizWGL
33
KI hilft am Deutschen Rheuma-Forschungszentrum Rheuma zu entschlüsseln. Wie funktioniert das? Julia Bidder sprach dazu mit PD Dr. Mir-Farzin Mashreghi vom DRFZ und Dr. Vikram Sunkara vom Zuse-Institut Berlin (ZIB). rheuma-liga.de/unser-einsatz…
1
119
Shared TCR Vβ21.3+ T cell immunological signature between MIS-A and MIS-C rupress.org/jhi/article/2/2/…
53
Mashreghi Lab Christmas dinner 🎄✨
Great food, great people, great science — the perfect way to close the year together. Looking forward to new projects and breakthroughs in 2026! #TeamScience
1
77
New paper on TGFβ and TNF in post-COVID syndrome great to see growing recognition of TGFβ pathway we previously described in long-term immune dysregulation following COVID-19. rdcu.be/ePG6V, rdcu.be/ePG7f, rdcu.be/ePG7U, rdcu.be/ePG8t






